Australian Clinical Labs Limited
ASX:ACL.AX
3.54 (AUD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| 23.934 | 35.901 | 178.244 | 60.373 | 41.255 | -10.524 | -9.012 | -24.031 |
| Depreciation & Amortization
| 128.427 | 122.755 | 106.096 | 88.052 | 77.902 | 11.506 | 11.318 | 12.51 |
| Deferred Income Tax
| 0 | -1.883 | -1.458 | -2.166 | -168.009 | -30.44 | 0 | 0 |
| Stock Based Compensation
| 3.064 | 1.883 | 1.458 | 2.166 | 0.323 | 0.321 | 0.308 | 0.293 |
| Change In Working Capital
| 0.487 | -6.241 | -10.519 | 13.004 | -11.539 | -5.079 | -4.16 | 9.239 |
| Accounts Receivables
| 0 | 17.404 | -28.119 | 2.749 | -16.803 | -3.767 | -3.449 | -0.958 |
| Inventory
| 0 | 4.996 | -3.898 | -2.261 | -0.828 | -0.423 | 0.573 | -0.005 |
| Accounts Payables
| 0 | -17.729 | 16.487 | 5.175 | 5.749 | -2.917 | 2.162 | 0 |
| Other Working Capital
| 0.487 | -10.912 | 5.011 | 7.341 | 0.343 | 2.028 | -3.446 | 10.202 |
| Other Non Cash Items
| 3.68 | -8.734 | 10.266 | -7.565 | 161.804 | 35.328 | 29.897 | 6.592 |
| Operating Cash Flow
| 159.592 | 143.681 | 284.087 | 153.864 | 101.736 | 1.112 | 4.693 | 4.603 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -6.505 | -6.934 | -21.252 | -9.506 | -9.381 | -14.362 | -8.635 | -7.458 |
| Acquisitions Net
| -1.067 | -5.248 | -50.791 | 2.364 | 0.11 | 1.365 | 0.29 | -4.545 |
| Purchases Of Investments
| 0 | 0 | 0 | -2.364 | -0.687 | -0.527 | -0.51 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 1.066 | -0.11 | 0.15 | 0 | 0 |
| Other Investing Activites
| 0.325 | -5.484 | -51.064 | 2.364 | 0.11 | 0.303 | 0.29 | 0.09 |
| Investing Cash Flow
| -7.247 | -12.182 | -72.043 | -6.076 | -9.958 | -13.374 | -8.855 | -11.913 |
| Financing Activities: | ||||||||
| Debt Repayment
| -124.06 | 66 | -100 | 52.01 | -60.916 | -7.271 | 1.047 | -0.375 |
| Common Stock Issued
| 0 | 0 | 0 | 146.254 | 0 | 14.41 | 0 | 0 |
| Common Stock Repurchased
| -1.742 | -0.891 | -4.944 | 0 | 0 | -0.527 | -0.51 | 0 |
| Dividends Paid
| -19.949 | -96.88 | -24.218 | -42 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.388 | -106.105 | -91.748 | -303.634 | 0 | 17.32 | 3.437 | 13.741 |
| Financing Cash Flow
| -146.139 | -137.876 | -220.91 | -147.37 | -60.916 | 9.522 | 3.974 | 13.366 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| -0.025 | -0.04 | 0.005 | -0.034 | -0.144 | 0.004 | 0.019 | -0.005 |
| Net Change In Cash
| 6.181 | -6.417 | -8.861 | 0.384 | 30.718 | -2.736 | -0.169 | 6.051 |
| Cash At End Of Period
| 26.136 | 19.955 | 26.372 | 35.233 | 34.849 | 4.131 | 6.867 | 7.036 |